Additionally, Kaplan–Meier survival analysis in glioma indicates that lower PINK1 levels correlate with better overall survival (Figure S7 and Figure 9a), further supporting its potential oncogenic role in glioblastoma and highlighting the need for functional validation. This evidence concerns the gene PINK1 and central nervous system cancer.